2022 Precision Oncology Patient Innovation Awards

NOW Open for Worldwide Submissions

Bayer is proud to support the second global Precision Oncology Patient Innovation Awards, aimed at fostering innovation and collaboration to improve access to precision oncology care and tackle inequities for people with cancer around the world.

Bayer is proud to support the second global Precision Oncology Patient Innovation Awards, aimed at fostering innovation and collaboration to improve access to precision oncology care and tackle inequities for people with cancer around the world.

Apply for the Precision Oncology Patient Innovation Awards

Deadline for Applications

Submissions must be received no later than 12:00 AM ET on May 16, 2022

2022 POPIA Program Timeline

Action Dates
Application Form submissions May 2021
Deadline for Application consideration July 15, 2021
Review Panel considers and rates eligible submissions July 2021
Review Panel informs applicants August 2021
Six applicants invited to develop Full Proposals August 2021
Deadline for Full Proposals September 2021
Applicants notified Early October 2021
Successful applicants announced publicly (Personalized Medicine
Awareness Month)
November 2021
    • Benefit access to tumor testing to inform patient diagnosis and care
    • Benefit access to tumor testing to inform patient diagnosis and care
    • Benefit access to tumor testing to inform patient diagnosis and care